Related haploidentical donors are a better choice than matched unrelated donors: Point
- PMID: 29296954
- PMCID: PMC5738988
- DOI: 10.1182/bloodadvances.2016002196
Related haploidentical donors are a better choice than matched unrelated donors: Point
Abstract
Publisher's Note: This article has a companion Counterpoint by Shaw. Publisher's Note: Join in the discussion of these articles at Blood Advances Community Conversations.
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
References
-
- Yakoub-Agha I, Mesnil F, Kuentz M, et al. ; French Society of Bone Marrow Transplantation and Cell Therapy. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol. 2006;24(36):5695-5702. - PubMed
-
- Kröger N, Zabelina T, de Wreede L, et al. ; MDS subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia. 2013;27(3):604-609. - PubMed
-
- Szydlo R, Goldman JM, Klein JP, et al. . Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15(5):1767-1777. - PubMed
-
- Wang Y, Liu Q-F, Xu L-P, et al. . Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125(25):3956-3962. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources